At HeadWay Clinic, we’re proud to offer innovative, evidence-based treatments like Esketamine (Spravato) and Ketamine therapy, providing hope and relief for individuals struggling with treatment-resistant depression, PTSD, and other mental health conditions. These groundbreaking therapies, backed by years of clinical research, are transforming lives by addressing symptoms quickly and effectively.
Both Esketamine and Ketamine work differently from traditional antidepressants, which target serotonin, dopamine, or norepinephrine systems. These therapies affect the NMDA receptor in the brain, a key player in regulating mood and cognitive function. By modulating this receptor, they promote neuroplasticity—essentially helping the brain form new connections and heal from long-standing patterns of distress.
Research has shown that this mechanism:
“Ketamine has been described as one of the most significant breakthroughs in depression treatment in decades.” — National Institute of Mental Health (NIMH)
These treatments are particularly effective for:
Emerging research also supports Ketamine’s potential for treating anxiety disorders, bipolar depression, and chronic pain conditions, although these uses are still under investigation.